Author

W Szafrański

Observed names: W Szafranski, W. Szafranski, W. Szafrański, Wojciech Szafranski, Wojciech Szafrański

Observed institutions: University of British Columbia, St. Paul's Hospital, Wojewódzki Szpital Specjalistyczny we Wrocławiu, St. Paul's Hospital, Centre for Heart Lung Innovation

OpenAlex ID: A5062318634

Efficacy and safety of budesonide/formoterol in the management of chronic obstructive pulmonary disease

2003 · W. Szafranski, A. Cukier, et al. · European Respiratory Journal · 882

PDF

A Pooled Analysis of FEV 1 Decline in COPD Patients Randomized to Inhaled Corticosteroids or Placebo

2007 · Joan B. Soriano, Don D. Sin, et al. · CHEST Journal · 128

A randomized, multicenter, open-label, phase III study of gemcitabine-cisplatin (GC) chemotherapy plus necitumumab (IMC-11F8/LY3012211) versus GC alone in the first-line treatment of patients (pts) with stage IV squamous non-small cell lung cancer (sq-NSCLC).

2014 · Nick Thatcher, Fred R. Hirsch, et al. · Journal of Clinical Oncology · 41

Efficacy and Safety of Necitumumab Continuation Therapy in the Phase III SQUIRE Study of Patients With Stage IV Squamous Non–Small-Cell Lung Cancer

2017 · Tudor Ciuleanu, Mark A. Socinski, et al. · Clinical Lung Cancer · 24

Analiza Grupy Chorych na śródmiąższowe Choroby płuc Hospitalizowanych w Latach 2000–2009 na Oddziale Płucnym Wojewódzkiego Szpitala w Radomiu

2012 · Wojciech Szafrański · Advances in respiratory medicine · 13

PDF

Domowe leczenie tlenem (DLT) w Polsce w latach 1986–2005

2007 · Wojciech Szafrański, Jan Zieliński, et al. · Advances in respiratory medicine · 6

PDF

Inhaled corticosteroids and mortality in chronic obstructive pulmonary disease

2006 · D.D. Sin, L. Wu, et al. · Respiratory Medicine COPD Update · 6

Occult Bronchial Foreign Bodies—Analysis of Own Material

2012 · Wojciech Szafrański, Jarosław Dobielski, et al. · Advances in respiratory medicine · 4

PDF

Squire: a Randomized, Multicenter, Open-Label, Phase III Study of Gemcitabine-Cisplatin (Gc) Chemotherapy Plus Necitumumab (Imc-11F8/Ly3012211) Vs Gc Alone in the First-Line Treatment of Patients (Pts) with Stage Iv Squamous Non-Small Cell Lung Cancer (Sq-Nsclc): Update on Key Subgroups

2014 · M.A. Socinski, L. Paz-Ares, et al. · Annals of Oncology · 3

Subgroup analyses by performance status (PS) in the phase III SQUIRE study: First-line necitumumab (N) plus gemcitabine-cisplatin (GC) vs. GC in squamous non-small cell lung cancer (NSCLC).

2015 · Mark A. Socinski, Alexander Luft, et al. · Journal of Clinical Oncology · 2

Safety and efficacy of necitumumab continuation therapy: Subgroup analysis of phase 3 SQUIRE study.

2015 · Tudor E. Ciuleanu, Mark A. Socinski, et al. · Journal of Clinical Oncology · 1

Efficacy and safety of necitumumab continuation therapy in phase 3 SQUIRE study

2015 · Tudor–Eliade Ciuleanu, Mark A. Socinski, et al. · Journal of Thoracic Oncology · 1

Final efficacy and safety results of ECOG Performance Status (PS) subgroup analyses from the SQUIRE phase III study

2015 · Mark A. Socinski, Alexander Luft, et al.

Safety and Efficacy of Necitumumab (N) During Single-Agent Treatment to Progression Following Gemcitabine-Cisplatin (GC) Chemotherapy Plus Necitumumab (IMC-11F8/LY3012211) in the First-Line Treatment of Patients With Stage IV Squamous Non-Small Cell Lung Cancer (sq-NSCLC) (SQUIRE)

2014 · M.A. Socinski, N. Thatcher, et al. · International Journal of Radiation Oncology*Biology*Physics

PDF

[Lung carcinoids diagnosed as small cell lung cancers--important diagnostic problem].

1995 · J Zych, J Słdkowska, et al. · PubMed

[Quality and results of year-long home oxygen therapy in Poland].

1992 · D Górecka, A Gawinkowska, et al. · PubMed

[Value of the MMEF/FEV1 index for the interpretation of spirographic data and the diagnosis of ventilatory disorders of the obstructive type].

1983 · W Szafrański · PubMed

[Deterioration of ventilation parameters following inhalation of fenoterol and salbutamol].

1981 · W Szafrański · PubMed

[BCG and levamisole in the treatment of advanced forms of lung cancer].

1980 · W Szafrański · PubMed

[Symptoms of chronic non-specific respiratory tract diseases in tuberculous patients and convalescents].

1978 · W Szafrański, M Durda, et al. · PubMed

[Value of mass radiophotography in diagnosing emphysema. Clinicoradiographic confrontation].

1977 · W Szafrański, L Smajkiewicz, et al. · PubMed

[Incidence of radiological symptoms of pulmonary emphysema found in the course of mass radiophotography of the rural population].

1977 · W Szafrański, L Smajkiewicz, et al. · PubMed

[Ventilatory disorders in tuberculous patients and convalescents].

1976 · W Szafrański, M Durda, et al. · PubMed

[Atmospheric pollution in a cement plant, tabacco smoking habit and occurrence of chronic bronchitis and pulmonary emphysema].

1976 · M Durda, E Ziemecka, et al. · PubMed

[Incidence of chronic bronchitis and pulmonary emphysema in the population of 3 villages of the Lublin Province].

1973 · M Durda, W Szafrański · PubMed

Works count: 33

Citation count: 1,111

H-index: 6

I10-index: 5